Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D E Mosier

Showing results (111-120 of 123) with videos related to

Pageof 13
Sort By:
AIDS Research and Human Retroviruses|August 1, 1992
Evaluation of gp160 vaccinees in the hu-PBL-SCID mouse modelD E Mosier, R J Gulizia, P MacIsaac, et al.
The Journal of Experimental Medicine|August 1, 1988
CD4+ T cells are required for development of a murine retrovirus-induced immunodeficiency syndrome (MAIDS)R A Yetter, R M Buller, J S Lee, et al.
AIDS (London, England)|June 1, 1995
Protection against HIV-1 infection in hu-PBL-SCID mice by passive immunization with a neutralizing human monoclonal antibody against the gp120 CD4-binding siteP W Parren, H J Ditzel, R J Gulizia, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 28, 1998
Inhibition of RNA polymerase II transcription in human cells by synthetic DNA-binding ligandsL A Dickinson, R J Gulizia, J W Trauger, et al.
European Journal of Immunology|August 1, 1990
Autoantibody production by severe combined immunodeficient mice reconstituted with synovial cells from rheumatoid arthritis patientsH Tighe, G J Silverman, F Kozin, et al.
Immunity|May 6, 1999
Neutralizing antibodies have limited effects on the control of established HIV-1 infection in vivoP Poignard, R Sabbe, G R Picchio, et al.
Journal of Virology|April 10, 1999
Highly potent RANTES analogues either prevent CCR5-using human immunodeficiency virus type 1 infection in vivo or rapidly select for CXCR4-using variantsD E Mosier, G R Picchio, R J Gulizia, et al.
AIDS Research and Human Retroviruses|May 1, 1992
EBV-induced human B cell lymphomas in hu-PBL-SCID miceD E Mosier, G R Picchio, M B Kirven, et al.
Viral Immunology|January 1, 1997
Common and idiosyncratic patterns of cytokine gene expression by Epstein-Barr virus transformed human B cell linesR Rochford, M J Cannon, R E Sabbe, et al.
Journal of Virology|June 26, 2009
Virus entry via the alternative coreceptors CCR3 and FPRL1 differs by human immunodeficiency virus type 1 subtypeR Nedellec, M Coetzer, N Shimizu, et al.
Pageof 13

Showing results (111-120 of 123) with videos related to

Sort By:
Pageof 13
AIDS Research and Human Retroviruses|August 1, 1992
Evaluation of gp160 vaccinees in the hu-PBL-SCID mouse modelD E Mosier, R J Gulizia, P MacIsaac, et al.
The Journal of Experimental Medicine|August 1, 1988
CD4+ T cells are required for development of a murine retrovirus-induced immunodeficiency syndrome (MAIDS)R A Yetter, R M Buller, J S Lee, et al.
AIDS (London, England)|June 1, 1995
Protection against HIV-1 infection in hu-PBL-SCID mice by passive immunization with a neutralizing human monoclonal antibody against the gp120 CD4-binding siteP W Parren, H J Ditzel, R J Gulizia, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 28, 1998
Inhibition of RNA polymerase II transcription in human cells by synthetic DNA-binding ligandsL A Dickinson, R J Gulizia, J W Trauger, et al.
European Journal of Immunology|August 1, 1990
Autoantibody production by severe combined immunodeficient mice reconstituted with synovial cells from rheumatoid arthritis patientsH Tighe, G J Silverman, F Kozin, et al.
Immunity|May 6, 1999
Neutralizing antibodies have limited effects on the control of established HIV-1 infection in vivoP Poignard, R Sabbe, G R Picchio, et al.
Journal of Virology|April 10, 1999
Highly potent RANTES analogues either prevent CCR5-using human immunodeficiency virus type 1 infection in vivo or rapidly select for CXCR4-using variantsD E Mosier, G R Picchio, R J Gulizia, et al.
AIDS Research and Human Retroviruses|May 1, 1992
EBV-induced human B cell lymphomas in hu-PBL-SCID miceD E Mosier, G R Picchio, M B Kirven, et al.
Viral Immunology|January 1, 1997
Common and idiosyncratic patterns of cytokine gene expression by Epstein-Barr virus transformed human B cell linesR Rochford, M J Cannon, R E Sabbe, et al.
Journal of Virology|June 26, 2009
Virus entry via the alternative coreceptors CCR3 and FPRL1 differs by human immunodeficiency virus type 1 subtypeR Nedellec, M Coetzer, N Shimizu, et al.
Pageof 13